These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35098746)

  • 1. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans.
    Newman TV; Gabriel N; Liang Q; Drake C; El Khoudary SR; Good CB; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2022 Feb; 28(2):266-274. PubMed ID: 35098746
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation.
    Yang L; Guo J; Liang Q; Newman TV; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1672-1679. PubMed ID: 34818086
    [No Abstract]   [Full Text] [Related]  

  • 4. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.
    Guo JS; He M; Gabriel N; Magnani JW; Kimmel SE; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1400-1409. PubMed ID: 36427343
    [No Abstract]   [Full Text] [Related]  

  • 5. Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.
    Chinthammit C; Bhattacharjee S; Axon DR; Slack M; Bentley JP; Warholak TL; Wilson DL; Lo-Ciganic WH
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1309-1316. PubMed ID: 32996396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does drug treatment for diabetes compare between Medicare Advantage prescription drug plans (MAPDs) and stand-alone prescription drug plans (PDPs)?
    Erten MZ; Stuart B; Davidoff AJ; Shoemaker JS; Bryant-Comstock L; Shenolikar R
    Health Serv Res; 2013 Jun; 48(3):1057-75. PubMed ID: 23205568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.
    Hernandez I; He M; Chen N; Brooks MM; Saba S; Gellad WF
    J Am Heart Assoc; 2019 Jun; 8(12):e011427. PubMed ID: 31189392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
    Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
    J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.
    Hernandez I; He M; Brooks MM; Saba S; Gellad WF
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):199-207. PubMed ID: 31523759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
    Zhou T; Liu P; Dhruva SS; Shah ND; Ramachandran R; Berg KM; Ross JS
    JAMA Intern Med; 2022 Feb; 182(2):185-195. PubMed ID: 34982097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.
    Rodriguez-Bernal CL; Peiró S; Hurtado I; García-Sempere A; Sanfélix-Gimeno G
    J Manag Care Spec Pharm; 2018 May; 24(5):440-448. PubMed ID: 29694286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
    Li P; Doshi JA
    PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
    Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access Restriction.
    Chen CC; De AP; Sweet B; Wade RL
    J Manag Care Spec Pharm; 2017 Aug; 23(8):902-912. PubMed ID: 28737985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
    Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
    J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.